VSK Medical Blog

A Great Story From A Patient Benefited From Our EECP® Therapy

May 31, 2016

A Great Story From A Patient Benefited From This Wonderful Therapy

Posted with the patient’s permission

I am 92 and have gone thru 15 sets of 35 EECP® treatments since 2000, the latest early last year. Drs have installed 10 heart related stents thru the years but only 3 are still functioning.

Read More>

EECP® Reported to Have Benefit for Patients with Type II Diabetes

May 31, 2016

This month a randomized clinical study entitled “Enhanced External Counterulsation (EECP®) Decreases Advanced Glycation End-Products and Proinflamatory Cytokines in Patients with Non-Insulin Dependent Type II Diabetes” was published in Acta Diabetologica, a scientific peer-reviewed journal that publishes reports of experimental and clinical research on diabetes and related metabolic diseases. The study, authored by PD Sardina, JS Martin,, JC Avery and RW Braith from the University of Florida, Gainesville, Auburn University and Edward Via College of Osteopathic Medicine  in Alabama, demonstrated that EECP® therapy significantly decreased fasting plasma glucose (FPG), significantly reduced A1c and cytokines (inflammatory markers), while significantly increasing nitric oxide.

Read More>

VSK Medical to Showcase External Counterpulsation and Patient Monitoring Devices at Medica

November 12, 2015

VSK Medical Limited (“VSK”) today announced its participation at the Medica World Conference of Medicine in Dusseldorf Germany November 16-19, 2015.

Medica 2015, one of the largest international healthcare conferences, will take place this year at the Dusseldorf Fairgrounds and will bring together the medical industry from Europe and around the world. The attendees will include medical distributors, sales representatives, healthcare providers, administrators and other industry professionals. The Medica conference was attended last year by more than 130,000 members of the healthcare community and had more than 4,500 exhibitors showcasing the latest trends transforming the industry.

Read More >  

esc logo

VSK Medical to Showcase External Counterpulsation Devices at ESC

Also Introducing New Ambulatory Monitoring Products from BIOX

August 20, 2015

VSK Medical Limited (“VSK”) today announced its participation of European Society of Cardiology (ESC) Congress 2015 from August 29 to September 2, 2015 in London, England.

The ESC Congress is one of the world’s largest and most influential annual event in cardiology. It has been attracting attendance from all over the world, this year with over 27,000 healthcare professionals from 140 countries.  The Congress Programme Committee has structured what they believe to be the best in science into 500 sessions with a distinguished faculty from around the globe and over 4,600 abstract presentations.  Over 180 companies will also showcase their technology and products during the event.

Read More >